This article explores the key challenges analytics and mass spectrometry solve within the biopharmaceutical industry.
Kelly Broster
Advertisement
Kelly Broster, PhD, is Senior Manager of Pharma & Biopharma Market Development and Collaborations at Thermo Fisher Scientific.
Articles by Kelly Broster
LCGC Europe
This instalment of “Perspectives in Modern HPLC” provides an overview of antibody–drug conjugates (ADCs) as a new class of biotherapeutics and describes their analytical characterization for quality assessment with examples from extensive applications libraries.
LCGC North America
Comprehensive characterization of ADCs requires increasingly powerful approaches consisting of small- and large-molecule techniques.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on LCGC International
1
Industry Roundup: Air Products Advances Gas Chromatography Performance
2
Fast Low-Pressure Chiral GC for Pesticides in Wine
3
Nano-LC-MS/MS Tracks Saliva in Multiple Sclerosis
4
AI/ML Now: Hybrid Machine Learning for Experiment-Efficient HPLC
5